Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 8.07%897M | -37.35%857M | -37.35%857M | -47.66%784M | -46.42%764M | -7.68%830M | 31.92%1.37B | 31.92%1.37B | 36.31%1.5B | 57.40%1.43B |
-Cash and cash equivalents | 4.10%864M | -55.34%611M | -55.34%611M | -47.66%784M | -46.42%764M | -7.68%830M | 31.92%1.37B | 31.92%1.37B | 36.31%1.5B | 57.40%1.43B |
-Short-term investments | --33M | --246M | --246M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Receivables | 1.72%6.58B | -8.41%5.95B | -8.41%5.95B | -11.39%5.9B | -1.18%6.38B | -6.00%6.47B | -14.18%6.5B | -14.18%6.5B | -6.83%6.66B | -22.27%6.46B |
-Accounts receivable | 4.50%5.55B | -13.32%4.58B | -13.32%4.58B | -14.64%4.66B | 0.31%5.19B | -5.95%5.31B | -15.25%5.28B | -15.25%5.28B | -9.04%5.46B | -25.99%5.18B |
-Taxes receivable | -15.29%471M | 5.41%643M | 5.41%643M | 9.73%643M | -4.99%685M | 12.32%556M | -10.82%610M | -10.82%610M | 0.86%586M | -4.63%721M |
-Other receivables | -7.14%559M | 20.76%727M | 20.76%727M | -2.48%591M | -10.00%504M | -18.65%602M | -7.38%602M | -7.38%602M | 8.99%606M | 0.54%560M |
Inventory | -0.72%11.55B | -3.22%11.57B | -3.22%11.57B | -4.26%10.75B | -12.26%10.44B | -21.24%11.63B | -19.05%11.96B | -19.05%11.96B | -15.49%11.22B | -17.83%11.9B |
Prepaid assets | -33.50%274M | -37.30%279M | -37.30%279M | -44.46%341M | 6.88%373M | -7.21%412M | 0.45%445M | 0.45%445M | 29.81%614M | -10.28%349M |
Restricted cash | -6.59%7.44B | -0.77%7.73B | -0.77%7.73B | -9.20%7.64B | -12.18%7.58B | -14.72%7.97B | -19.98%7.79B | -19.98%7.79B | -17.53%8.41B | -20.04%8.63B |
Other current assets | 35.14%200M | 34.13%224M | 34.13%224M | -12.12%58M | 2.04%100M | 2.78%148M | 9.15%167M | 9.15%167M | 24.53%66M | -60.64%98M |
Total current assets | -3.88%27.88B | -6.88%27.72B | -6.88%27.72B | -12.76%26.63B | -12.14%26.96B | -15.50%29.01B | -15.94%29.77B | -15.94%29.77B | -11.71%30.52B | -18.49%30.69B |
Non current assets | ||||||||||
Net PPE | 3.81%12.33B | 4.06%12.2B | 4.06%12.2B | 6.69%12.12B | 5.82%11.92B | 7.07%11.88B | 6.33%11.72B | 6.33%11.72B | 7.28%11.36B | 5.46%11.27B |
-Gross PPE | 3.93%30.68B | 3.46%30.26B | 3.46%30.26B | 5.39%30.21B | 4.30%29.72B | 4.91%29.52B | 4.95%29.24B | 4.95%29.24B | 5.46%28.66B | 4.46%28.49B |
-Accumulated depreciation | -4.01%-18.34B | -3.06%-18.06B | -3.06%-18.06B | -4.54%-18.09B | -3.31%-17.8B | -3.50%-17.64B | -4.05%-17.52B | -4.05%-17.52B | -4.29%-17.3B | -3.82%-17.23B |
Goodwill and other intangible assets | -2.50%6.88B | 6.75%6.77B | 6.75%6.77B | 9.50%7B | 6.54%6.97B | 7.11%7.05B | -3.10%6.34B | -3.10%6.34B | 0.44%6.39B | -0.08%6.54B |
-Goodwill | --4.62B | 9.90%4.51B | 9.90%4.51B | ---- | ---- | ---- | -1.42%4.1B | -1.42%4.1B | ---- | ---- |
-Other intangible assets | --2.25B | 0.98%2.26B | 0.98%2.26B | ---- | ---- | ---- | -6.05%2.24B | -6.05%2.24B | ---- | ---- |
Investments and advances | -9.77%5.02B | -4.07%5.28B | -4.07%5.28B | -5.98%5.14B | -1.91%5.56B | 0.74%5.57B | 0.60%5.5B | 0.60%5.5B | 0.74%5.47B | 3.68%5.67B |
Other non current assets | -2.86%1.29B | 0.69%1.31B | 0.69%1.31B | -2.81%1.31B | -3.95%1.29B | 4.24%1.33B | -2.10%1.3B | -2.10%1.3B | -0.22%1.35B | -9.88%1.34B |
Total non current assets | -1.18%25.52B | 2.77%25.55B | 2.77%25.55B | 4.08%25.57B | 3.72%25.74B | 5.51%25.83B | 2.05%24.86B | 2.05%24.86B | 3.52%24.57B | 2.61%24.81B |
Total assets | -2.61%53.4B | -2.49%53.27B | -2.49%53.27B | -5.25%52.2B | -5.05%52.7B | -6.75%54.83B | -8.60%54.63B | -8.60%54.63B | -5.51%55.09B | -10.24%55.5B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -9.50%5.6B | -13.72%5.84B | -13.72%5.84B | -6.38%5.38B | -4.98%5.53B | -9.59%6.19B | -19.51%6.77B | -19.51%6.77B | -19.30%5.75B | -8.19%5.82B |
-accounts payable | -8.00%5.15B | -12.32%5.54B | -12.32%5.54B | -6.49%4.91B | -0.87%5.04B | -10.72%5.6B | -19.10%6.31B | -19.10%6.31B | -19.73%5.25B | -9.32%5.08B |
-Total tax payable | -11.02%452M | -33.11%305M | -33.11%305M | -9.55%379M | -8.52%408M | 78.25%508M | 18.75%456M | 18.75%456M | 19.03%419M | -13.40%446M |
-Other payable | ---- | ---- | ---- | 17.95%92M | -70.75%86M | -71.23%84M | ---- | ---- | -65.94%78M | 32.43%294M |
Current accrued expenses | -13.90%1.31B | 8.67%1.42B | 8.67%1.42B | -9.36%1.34B | 2.74%1.35B | 14.83%1.52B | -11.65%1.3B | -11.65%1.3B | -3.72%1.48B | -8.36%1.32B |
Current debt and capital lease obligation | 86.08%3.78B | 614.53%2.9B | 614.53%2.9B | 567.96%2.75B | 258.79%2.61B | -33.30%2.03B | -76.63%406M | -76.63%406M | -69.44%412M | -80.52%728M |
-Current debt | 99.94%3.47B | 2,331.13%2.58B | 2,331.13%2.58B | 2,000.85%2.46B | 442.96%2.31B | -37.16%1.74B | -92.66%106M | -92.66%106M | -89.06%117M | -87.67%426M |
-Current capital lease obligation | 5.37%314M | 8.00%324M | 8.00%324M | -0.34%294M | -0.99%299M | 3.83%298M | 2.74%300M | 2.74%300M | 5.73%295M | 7.09%302M |
Current deferred liabilities | -3.93%8.34B | -2.09%8.46B | -2.09%8.46B | -7.77%8.03B | -12.96%7.83B | -12.31%8.68B | -18.08%8.64B | -18.08%8.64B | -19.21%8.71B | -22.74%9B |
Other current liabilities | -13.31%847M | -11.72%972M | -11.72%972M | -16.27%1.15B | -34.19%1.07B | -26.10%977M | -28.65%1.1B | -28.65%1.1B | -20.61%1.37B | -23.48%1.63B |
Current liabilities | 2.24%20.17B | 6.84%19.94B | 6.84%19.94B | 4.96%19B | -0.55%18.68B | -13.20%19.73B | -22.86%18.66B | -22.86%18.66B | -21.06%18.11B | -26.78%18.79B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -6.65%8.64B | -6.02%8.64B | -6.02%8.64B | -5.40%8.6B | 1.84%9.26B | 8.86%9.26B | 7.47%9.19B | 7.47%9.19B | 8.27%9.09B | 3.38%9.1B |
-Long term debt | -7.87%7.6B | -8.22%7.58B | -8.22%7.58B | -7.86%7.58B | 0.04%8.25B | 6.46%8.25B | 6.77%8.26B | 6.77%8.26B | 7.21%8.22B | 2.26%8.24B |
-Long term capital lease obligation | 3.37%1.04B | 13.53%1.06B | 13.53%1.06B | 17.94%1.02B | 19.23%1.02B | 33.42%1.01B | 14.09%931M | 14.09%931M | 19.50%864M | 15.58%853M |
Non current deferred liabilities | -8.21%1.19B | -3.13%1.27B | -3.13%1.27B | -8.06%1.28B | -4.59%1.29B | -5.21%1.29B | -6.63%1.31B | -6.63%1.31B | -15.19%1.39B | -14.44%1.35B |
Other non current liabilities | 0.79%1.02B | -0.80%997M | -0.80%997M | 13.46%1.05B | 1.63%1B | 0.49%1.02B | -0.89%1.01B | -0.89%1.01B | -8.56%929M | -10.71%984M |
Total non current liabilities | -6.17%10.85B | -5.23%10.9B | -5.23%10.9B | -4.19%10.93B | 1.06%11.55B | 6.32%11.56B | 4.90%11.5B | 4.90%11.5B | 3.24%11.41B | -0.43%11.43B |
Total liabilities | -0.87%31.02B | 2.23%30.84B | 2.23%30.84B | 1.42%29.93B | 0.06%30.24B | -6.88%31.29B | -14.20%30.17B | -14.20%30.17B | -13.16%29.51B | -18.63%30.22B |
Shareholders'equity | ||||||||||
Share capital | 19.34%3.25B | 2.19%3.22B | 2.19%3.22B | 2.17%3.21B | 2.30%3.2B | -12.43%2.72B | 0.22%3.15B | 0.22%3.15B | 0.96%3.14B | 2.02%3.13B |
-common stock | 19.34%3.25B | 2.19%3.22B | 2.19%3.22B | 2.17%3.21B | 2.30%3.2B | -12.43%2.72B | 0.22%3.15B | 0.22%3.15B | 0.96%3.14B | 2.02%3.13B |
Retained earnings | -4.72%21.98B | -6.53%21.93B | -6.53%21.93B | -12.52%21.61B | -9.97%21.83B | -4.74%23.07B | -0.77%23.47B | -0.77%23.47B | 6.93%24.7B | 4.09%24.24B |
Gains losses not affecting retained earnings | -20.93%-3.11B | -20.14%-2.99B | -20.14%-2.99B | -8.77%-2.84B | -18.37%-2.88B | -4.34%-2.57B | 0.88%-2.49B | 0.88%-2.49B | -18.04%-2.61B | -23.82%-2.43B |
Total stockholders'equity | -4.74%22.12B | -8.14%22.17B | -8.14%22.17B | -12.90%21.97B | -11.19%22.15B | -6.60%23.22B | -0.63%24.13B | -0.63%24.13B | 5.13%25.23B | 2.24%24.94B |
Noncontrolling interests | -17.81%263M | -21.02%263M | -21.02%263M | -17.00%293M | -7.94%313M | -5.04%320M | 0.30%333M | 0.30%333M | 9.63%353M | 15.65%340M |
Total equity | -4.92%22.38B | -8.31%22.43B | -8.31%22.43B | -12.95%22.27B | -11.15%22.46B | -6.58%23.54B | -0.61%24.47B | -0.61%24.47B | 5.19%25.58B | 2.40%25.28B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |